Geron-logo-black-xsmall.png
Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting
December 06, 2016 16:01 ET | Geron Corporation
MENLO PARK, Calif., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced four presentations of exploratory preclinical and clinical data related to the imetelstat...
Geron-logo-black-xsmall.png
Geron Announces November Investor Conference Presentation Webcasts
November 07, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron-logo-black-xsmall.png
Geron Corporation Reports Third Quarter 2016 Financial Results and Recent Events
November 03, 2016 16:05 ET | Geron Corporation
MENLO PARK, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2016 and recent events. For...
Geron-logo-black-xsmall.png
Geron Announces Presentations at American Society of Hematology Annual Meeting
November 03, 2016 09:12 ET | Geron Corporation
MENLO PARK, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that four abstracts related to the imetelstat program have been accepted for presentation at...
Geron-logo-black-xsmall.png
Geron Announces Conference Call to Discuss Third Quarter 2016 Financial Results
October 26, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2016, on Thursday, November 3,...
Geron-logo-black-xsmall.png
Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
September 12, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today provided updates on the clinical trials being conducted by Janssen Research & Development, LLC, of...
Geron-logo-black-xsmall.png
Geron Announces Conference Call on September 12 at 8:00 A.M. Eastern Time
September 11, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., Sept. 11, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on September 12, 2016, at 8:00 a.m. Eastern Time to provide an update on the...
Geron-logo-black-xsmall.png
Geron Corporation Reports Second Quarter 2016 Financial Results and Recent Events
August 03, 2016 16:05 ET | Geron Corporation
MENLO PARK, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and six months ended June 30, 2016 and recent events. For the...
Geron-logo-black-xsmall.png
Geron Announces Conference Call to Discuss Second Quarter 2016 Financial Results
July 27, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the second quarter ended June 30, 2016, on Wednesday, August 3, 2016,...
Geron-logo-black-xsmall.png
Geron Announces Issuance of U.S. Patents Related to Imetelstat
July 13, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., July 13, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the recent issuance of three U.S. patents related to the company’s telomerase inhibitor,...